SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    New York Cannabis Regulator’s ‘Catastrophic’ Blunder Threatens Over 100 Businesses

    By

    Over 100 legal New York cannabis dispensaries could be forced to relocate following a monumental blunder from the state’s Office of Cannabis Management (OCM).

    New York’s OCM and its bigger brother, the Cannabis Control Board (CCB), are no strangers to controversy or criticism.

    Over the last two years, they have been continuously sued by operators, embroiled in scandals over the financing of their CUARD scheme, described as ‘disastrous’ by Governor Kathy Hochul, and endured a scathing ‘top-down’ internal review (among many other failures).

    Now, in what has been described as a ‘catastrophic failure of governance’, the OCM announced this week that for over two years, it has been approving cannabis store locations based on the wrong zoning rule.

    According to its statement, the OCM has been assessing whether dispensaries are too close to a school or place of worship using a door-to-door measurement, similar to how liquor stores are regulated.

    However, New York’s cannabis law says dispensaries must be at least 500 feet away from a school’s entire property line, not just the front door.

    In effect, this means that 105 licensed cannabis businesses (60 of which are operational) are now in violation of this zoning rule, alongside 47 applicants who are currently in various stages of being approved.

    Governor Hochul described the situation as a ‘critical oversight’ by former OCM leadership, and is now seeking legislative changes to mitigate the issue for license holders already in operation.

    A spokesperson for Hochul said: “At her direction, the State is taking immediate action to support cannabis store owners impacted by this issue. We are laser-focused on making sure these small business owners, who have poured their heart and soul into these shops, aren’t left paying the price for the previous leadership’s screw-up.”

    Meanwhile, a new fund has been set up to support businesses affected, many of which have spent years and tens, sometimes hundreds of thousands of dollars, establishing their stores.

    The state is launching a $15 million ‘Applicant Relief Program’, in which eligible applicants still in process may receive up to $250,000 to help cover relocation or compliance costs. Notably, this will only cover applicants, and not those already licensed.

    Despite efforts to amend legislation and enable businesses to keep their premises, the OCM acknowledged there is no guarantee the legislature will approve the proposed fix, leaving some licensees in limbo.

    Unsurprisingly, this latest blunder has drawn fierce criticism from all sides.

    Boris Jordan, Curaleaf Chairman and CEO, went as far as suggesting that ‘the OCM blatantly and knowingly disregarded the MRTA’s (Marijuana Regulation and Taxation Act’s) proximity provisions, violating both state and federal law on multiple bases.’

    “Dispensaries and their owners should not suffer due to the intentional disregard for the law by the OCM and the administration. The state must be held accountable.

    “After the MRTA (passed, we believed that New York had a shot at building one of the country’s greatest cannabis markets. But instead, we’ve seen a pattern of reckless decisions, blatant disregard for business owners, patients and customers and more. These failures have driven consumers straight back into the illicit market, robbing the state of tax dollars and job opportunities.

    “To every licensee impacted by the OCM’s zoning error: join us in fighting this lawlessness and ensuring the state solves this for New Yorkers. Contact us at NYFightsBack@Curaleaf.com to stand with us.”

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free